Effect of JAK inhibitors on extraintestinal manifestations and concurrent immune-mediated inflammatory diseases in patients with inflammatory bowel disease.
M. Truyens
X. Tolstoy
G. Calabrese
Anneline Cremer
K. Lewandowski
Konstantinos Argyriou
I. Drygiannakis
E. Shakweh
P. Pastras
H. Kani
María José García
H. Gordon
D. Ribaldone
K. Karmiris
Carla Felice
Irene Moraleja Yudego
Andreas Blesl
Alessia Todeschini
P. Balestrieri
R. Filip
T. Taelman
N. Vladimirova
G. Michalopoulos
M. Attauabi
L. Pouillon
N. Noor
T. Innocenti
Sophie Vieujean
T. Karakan
Manuel Barreiro-de Acosta
G. Mocci
M. Estevinho
E. Savarino
A. Jauregui-Amezaga
T. Holvoet
C. Kapizioni
G. Dağcı
S. Vrakas
C. Hedin
O. Nardone
Grażyna Rydzewska
I. Koutroubakis
Ioannis Psaroudakis
G. Dragoni
J. Geldof
G. Varkas
J. Lambert
T. Lobatón
Medicine